(S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2

CAT:
804-HY-168349
Size:
Inquire

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 - image 1

(S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2

  • UNSPSC Description:

    (S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 is the coupling conjugate of the E3 ubiquitin ligase ligand and linker for NX-2127 (HY-153220)[1].
  • Target Antigen:

    E3 Ligase Ligand-Linker Conjugates
  • Type:

    Reference compound
  • Related Pathways:

    PROTAC
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/s-thalidomide-pyrrolidine-c-piperidine-ph-nh2.html
  • Smiles:

    O=C1C2=CC(N3C[C@H](CN4CCC(C5=CC=C(N)C=C5)CC4)CC3)=CC=C2C(N1C6C(NC(CC6)=O)=O)=O
  • Molecular Weight:

    515.60
  • References & Citations:

    [1]Robbins D W, et al. Discovery and preclinical pharmacology of NX-2127, an orally bioavailable degrader of Bruton’s tyrosine kinase with immunomodulatory activity for the treatment of patients with B cell malignancies[J]. Journal of Medicinal Chemistry, 2024, 67(4): 2321-2336.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported